πŸ‡ΊπŸ‡Έ FDA
Patent

US 9365604

Oligomer-nucleoside phosphate conjugates

granted A61KA61K47/60A61P

Quick answer

US patent 9365604 (Oligomer-nucleoside phosphate conjugates) held by Nektar Therapeutics expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K47/60, A61P, A61P35/00